Abstract : The organization of medical care to patients with diabetes who have complications — diabetic reti-nopathy, in the Republic of Uzbekistan was studied. Keywords: diabetic retinopathy, organization of specialized ophthalmologic help. Relevance and purpose of the work.- Diabetic retinopathy (DR) is a leading cause of blindness in people of working age in developed countries. It accounts 80–90% of all disability due to diabetes mellitus (DM) [1, 10–14; 5, 35–37; 7, 13–15; 10, 354–356; 14, 1195–1200]. WHO experts predict that by 2025 the number of diabetics will ex-ceed 300 million people. However, this forecast may be too “optimistic”. The number of registered patients with diabetes mellitus (DM) in 2000 was 11 % higher than the estimates of WHO experts [13, 1414–1431]. Rising incidence of diabetes has an impact on the level of disability, in patients with dia-betes type 1, in 5 years after the onset of disease symptoms DR detected in 25 % of cases, in 10 years — nearly 60 %, and in 15 years — 80 % [10, 354–356]. According to the Wiscon-sin Epidemiologic Study of Diabetic Retinopathy (WESDR), proliferative retinopathy — the greatest threat to vision, was noted in approximately 50 % of patients with duration of dia -betes type 1–20 years and more [4, 20–27]. In DM type 2, which is 90–95% of all cases of the disease, due to the late diagnosis, signs of DR are revealed at the time of diagnosis of diabetes in 15–30% of cases, in 10 years — 50–60 %, and in 30 years — in more than 90% of patients. Proliferative processes observed in 2% of patients with diabetes for less than 5 years, and 25% of those with diabetes for 25 years or more [11, 1235–1241; 14, 1195–1200].According to WESDR 60% of adult diabetic patients (over 30 years) not treated with insulin, had retinopa-thy in 25 years, while 10% — proliferative form. Among older patients receiving insulin diabetes due to severity of DM, over 80% have retinopathy after 15 years of the dis -ease and 10% had a proliferative retinopathy. Over 20 % of patients were suffering from retinopathy at the moment of diagnosis of type 2 diabetes. Almost 100% of patients with type 1 diabetes had retinopathy developed after 15 years from the onset of the disease, and about 25% of patients had proliferative DR.Since type 2 diabetes is much more common than type 1 diabetes, this form of the disease may be considered as the main cause of vision loss in patients aged 20 to 74 years [3, 4–5; 6, 80–81; 12, 642–652].In Uzbekistan, according to ShagazatovaB.H. (2004), one of the leading reasons that led to disability (after diabetes that caused more than 50 % disability), was diabetic retinopa -thy — 7.0% [8, 41–50; 9, 3–5]. However, according to the data of the Executive Committee of the CIS, in our country, the number of diabetic patients in the last 10 years is increas -ing annually by 8 %. Currently there are more than 90,000 pa -tients registered, however, considering the fact that at least 2 % of the population of Central Asia have diabetes, and the popu-lation of Uzbekistan is 27 million, the real number of patients with diabetes is at least 6 bigger times and according to fore-casts is more than 500,000, and the number of persons with disabilities due to diabetic retinopathy — over 20,000.It should be understood that if in other complications of diabetes there are at least some, even palliative therapies (such as neuropathic with CRF — replacement therapy in the form of hemodialysis, in diabetic foot — surgical aids et al.), in the loss of vision due to DR, there are no even symptomatic treatments. This makes prevention the only affordable and effective method of care for patients with dia -betes. Considering the scale of the problem and the huge moral and economic damage to the person, family, society, the need becomes clear to study the situation and assess the adequacy of care provided to patients and ongoing preven-tion of DR, to develop and propose ways to prevent this terrible complication.